Link, Jr.; Charles J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Link, Jr.; Charles J..The latest application filed is for "antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase".

Company Profile

0.13.7

Link, Jr.; Charles J. - Clive IA
Link, Jr.; Charles J. - Des Moines IA
Link, Jr.; Charles J. - Ames IA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase Grant 9,474,801 - Link, Jr. , et al. October 25, 2	2016-10-25
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase Grant 9,474,771 - Link, Jr. , et al. October 25, 2	2016-10-25
Antitumor Vaccination Using Allogeneic Tumor Cells Expressing Alpha (1,3)-galactosyltransferase App 20140072597 - LINK, JR.; Charles J. ; et al.	2014-03-13
Antitumor Vaccination Using Allogeneic Tumor Cells Expressing Alpha (1,3)-galactosyltransferase App 20140037692 - LINK, JR.; Charles J. ; et al.	2014-02-06
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase Grant 8,551,474 - Link, Jr. , et al. October 8, 2	2013-10-08
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase Grant 8,535,658 - Link, Jr. , et al. September 17, 2	2013-09-17
Rhamnose And Forssman Conjugated Immunogenic Agents App 20130149331 - Wang; Peng George ; et al.	2013-06-13
Antitumor Vaccination Using Allogeneic Tumor Cells Expressing Alpha (1,3)-galactosyltransferase App 20110250233 - Link, JR.; Charles J. ; et al.	2011-10-13
Antitumor Vaccination Using Allogeneic Tumor Cells Expressing Alpha (1,3)-galactosyltransferase App 20110086067 - LINK, JR.; Charles J. ; et al.	2011-04-14
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyl transferase Grant 7,763,461 - Link, Jr. , et al. July 27, 2	2010-07-27
Methods and compositions for efficient gene transfer using transcomplementary vectors Grant 7,125,549 - Higginbotham , et al. October 24, 2	2006-10-24
Methods And Compositions For Efficient Gene Transfer Using Transcomplementary Vectors App 20060216271 - Higginbotham; James N. ; et al.	2006-09-28
Selectable gene marker system based on expression of N-acetyllactosaminide 3-.alpha. galactosyltransferase Grant 7,078,179 - Di Colandrea , et al. July 18, 2	2006-07-18
Human suppressor tRNA oligonucleotides and methods for use for same Grant 7,029,665 - Panchal , et al. April 18, 2	2006-04-18
Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect Grant 7,005,126 - Link, Jr. , et al. February 28, 2	2006-02-28
Differential inactivation of nucleic acids by chemical modification Grant 5,843,459 - Wang , et al. December 1, 1	1998-12-01
Herpes simplex virus amplicon mini-vector gene transfer system Grant 5,830,727 - Wang , et al. November 3, 1	1998-11-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.